Kenvue Inc. (KVUE) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.

Total Revenue Chart for Kenvue Inc.

Kenvue Inc. (KVUE) revenue for FY2025 was USD 15.1B, a -2.1% change from FY2024. Kenvue Inc.'s revenue grew from USD 14.3B in 2019 to USD 15.1B in 2025 (5.6% over 6 years). Earnings per share grew from USD 0.76 in 2019 to USD 1.09 in 2022 (43.5%). Revenue compound annual growth rate: 5-year CAGR of 0.9%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$37.11B
Implied Share Price
$19.31
Enterprise Value
$44.41B
Revenue (TTM)
$15.53B
EBITDA
$3.51B
Profit Margin
10.88%
Trailing P/E
21.94
Forward P/E
16.10
Price/Book (MRQ)
3.65
Price/Sales (TTM)
2.39
EV/EBITDA
13.47
EV/Revenue
2.86
Dividend Yield
4.22%
Book Value
$5.29
Free Cash Flow (FY2025)
$1.72B
Free Cash Flow Yield
4.64%

Snapshot as of 31st October 2026 — not point-in-time controlled, may lag the live market by a few days.